Experience With Extended Follow-Up of Prophylactically Implanted Defibrillators for High-Risk Patients With Hypertrophic Cardiomyopathy
JACC Adv
.
2024 Oct 9;3(11):101317.
doi: 10.1016/j.jacadv.2024.101317.
eCollection 2024 Nov.
Authors
Barry J Maron
1
,
Susan Casey
2
,
Jay D Sengupta
2
,
Scott W Sharkey
2
,
Martin S Maron
1
,
Ethan J Rowin
1
Affiliations
1
Hypertrophic Cardiomyopathy Center, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.
2
Joseph F. Novogratz Family Heart Rhythm Science Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.
PMID:
39444582
PMCID:
PMC11497377
DOI:
10.1016/j.jacadv.2024.101317
No abstract available
Keywords:
hypertrophic cardiomyopathy; implanted defibrillators; sudden death.